DEA had the full opioid data, not the pharmaceutical wholesale distributors

DEA had the full opioid data, not the pharmaceutical wholesale distributors

Publication date: Aug 13, 2019

John M. Gray , Opinion contributor Published 6:46 p. m. CT Aug. 12, 2019 The prescription opioid abuse crisis is complex, but it can be addressed if we are honest about its causes: Opposing view As part of the national debate about the opioid epidemic and its causes, pharmaceutical wholesale distributors have been the subject of a variety of unfounded claims, most notably the myth that distributors could have unilaterally stemmed the crisis.

OUR VIEW: Drugmakers and distributors made and sold pills ‘like Doritos’ Distributors are committed to working collaboratively to reverse this epidemic, and the industry has endorsed a range of policy measures that will go a long way toward ensuring that opioid prescriptions are better tracked and managed.

The prescription opioid abuse crisis is complex, but it can be addressed if we are honest about its causes and work together to move beyond misleading rhetoric and misplaced blame and toward practical problem solving.

Concepts Keywords
Chief Executive Officer Heroin
Critical Point Oxycodone
DEA Opioid epidemic
Epidemic Morphine
John Gray Morphinans
Logistics Euphoriants
Opioid Psychoactive drugs
Opioid Epidemic Opioids
Opioids RTT
Oxycodone Green light manufacturers
Pharmaceutical Pharmaceutical wholesale distributors
Pharmacy Blame distributors
Physician Myth distributors
Rhetoric
Supply Chain

Semantics

Type Source Name
disease MESH opioid abuse
disease DOID opioid abuse
pathway BSID Release
gene UNIPROT SET
gene UNIPROT NR4A2
gene UNIPROT ALG3
drug DRUGBANK Oxycodone
gene UNIPROT TNFSF14
gene UNIPROT SLAMF8
drug DRUGBANK Tropicamide

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *